[Rotavirus gastroenteritis and its vaccination].

Area of Science:

• Virology
• Epidemiology
• Immunology

Background:

• Rotavirus infection is a leading cause of severe diarrhea in infants and children worldwide, posing a significant global health burden.
• Rotavirus gastroenteritis (RVGE) lacks specific antiviral treatments, highlighting the need for preventive measures.
• Group A rotavirus (RV) is the primary cause of acute gastroenteritis, with infants aged 3-24 months experiencing the most severe symptoms.

Purpose of the Study:

• To review the etiology, epidemiology, disease burden, and vaccine landscape of rotavirus infections.
• To evaluate the effectiveness of current rotavirus vaccines in preventing RV infection and reducing disease burden.
• To propose recommendations for optimizing rotavirus vaccine application and integration into China's national child immunization program.

Main Methods:

• Literature review of rotavirus etiology, epidemiology, and disease burden.
• Analysis of rotavirus vaccine efficacy and impact on infection rates and mortality.
• Examination of technical considerations for rotavirus vaccine implementation in China.

Main Results:

• Group A rotavirus is the predominant cause of RVGE, affecting all age groups but most severely impacting infants.
• RVGE exhibits seasonal patterns, with peak incidence during winter months.
• Increased rotavirus vaccination rates have been shown to decrease the incidence and mortality associated with rotavirus diarrhea in infants.

Conclusions:

• Rotavirus vaccination is a crucial strategy for reducing the global burden of rotavirus gastroenteritis.
• Further research and strategic planning are needed to effectively integrate rotavirus vaccines into national immunization schedules, particularly in China.
• Optimizing vaccine strategies can significantly mitigate the impact of rotavirus on child health.